
Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a patient and doctor. To celebrate the 100th episode of The Bloodline with LLS, we will be speaking with Mel Mann, a chronic myeloid leukemia (CML) survivor and Dr. Brian Druker, a physician researcher at Oregon Health Sciences University (OHSU).
Mel shares how Dr. Druker’s research saved his life with the drug, Gleevec®, and we get to hear his inspirational message of how one person can make a difference. Dr. Druker discusses this revolutionary therapy, how it transformed the lives of CML patients like Mel, and how targeted treatments are continuing to transform how we treat cancer.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Chronic Myeloid Leukemia
- The rise of precision medicine for patients with CML
- TKI Therapy
- Be The Match – Bone Marrow Donor Registry
- LLS Translational Research
- LLS Specialized Centers of Research Program
- Beat AML Master Clinical Trial
- Oral Parity Laws
- LLS Advocacy
- Clinical Trial Support Center
- LLS Myeloma Link
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Financial support
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by Pfizer.